Prostate Cancer Specialist Chooses Proton Therapy at ProCure
News related to:ProCure Proton Therapy Center · 1 min read
SOMERSET, N.J., Sept. 25, 2026 /CourierPR/ -- ProCure Proton Therapy Center, the first proton therapy facility in the tri-state region, has highlighted a unique patient story during National Prostate Cancer Awareness Month. Dr. Edward Soffen, a radiation oncologist with over 30 years of experience, chose proton therapy at ProCure for his own prostate cancer, a decision he says he has no regrets about.
Dr. Soffen, who has performed nearly every radiation technique for prostate cancer, including CyberKnife, radioactive seed implants, high-dose-rate brachytherapy, conventional radiation with IMRT, and protons, faced a complex decision. With multiple treatment options available, he carefully considered his own case, exploring six different modalities. Ultimately, he chose proton therapy, a choice he attributes to its ability to deliver a precise dose to the tumor while sparing surrounding healthy tissue.
Dr. Soffen's decision was influenced by his long-standing relationship with the ProCure team. As a prostate cancer specialist for over three decades, he has seen the ProCure team treat thousands of complex cases with a personalized approach. When it was his turn to be the patient, he trusted the team's expertise and the facility's commitment to patient care.
ProCure Proton Therapy Center, which opened in March 2012, has treated over 8,000 patients, including 750+ pediatric patients from the U.S. and abroad. The center offers a range of treatments for various cancers, including prostate, breast, lung, brain, head and neck, and gastrointestinal system, as well as sarcomas and many pediatric cases. Using the most advanced radiation treatment available, ProCure enables many cancer patients to choose a non-surgical treatment personalized to their medical needs and lifestyles, often with fewer side effects and less downtime.
Dr. Soffen's decision to undergo proton therapy at ProCure underscores the importance of personalized treatment plans in cancer care. His experience as both a patient and a provider highlights the critical role that trust and expertise play in patient decision-making.